I'm always working toward health equity. My goal is to bring the same innovative approaches and great outcomes to all patients.
Where I see patients (1)
Selected research
-
Fludarabine Pharmacokinetic Model-Based Dosing Minimizes the Risk of Graft Rejection in Pediatric Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.
Transplantation and cellular therapy
-
Role of race and ethnicity in survival among children/young adults with relapsed ALL: a Children's Oncology Group report.
Blood advances
-
Real-world outcomes of infections following tisagenlecleucel in patients with B-cell ALL: a CIBMTR analysis.
Blood advances
Contact me
Learning never stops
Our classroom and bedside classes help kids get credit and keep learning during treatment.
See our school program
